R Hood, V Valentine, S Mac, WH Polonsky - Diabetes Spectrum, 2006 - Am Diabetes Assoc Exenatide was approved by the Food and Drug Administration in 2005 as an
adjunctive therapy to metformin and/or sulfonylurea regimens for individuals
with type 2 diabetes who have not achieved adequate glycemic control. ... Cited by 2 - Related articles - BL Direct - All 2 versions
[CITATION] Intensive management of type 1 diabetes
S Brunton - The American Journal of Medicine, 2008 - Elsevier Insulin therapy is integral to the treatment of diabetes mellitus. Epidemiologic
studies have shown its benefits both in terms of improving glycemic control and
reducing the risk for long-term diabetic complications for both type 1 and ... Cited by 3 - Related articles - All 18 versions
[CITATION] Incretin-based therapies for type 2 diabetes
JR White - Clinical Diabetes, 2008 - Am Diabetes Assoc Adecade and a half ago, the choice of an oral antihyperglycemic agent for any
particular patient was in some ways a debate of nuance. Sulfonylureas (SUs) were
the only class available, and providers were left to sift though ... Cited by 3 - Related articles - BL Direct - All 2 versions
J Unger - The American Journal of Medicine, 2008 - Elsevier Diabetes mellitus is a chronic progressive disease that has profound
consequences for individuals, families, and society. Despite clear glycemic
control targets articulated by the major medical societies, patients and ... Cited by 5 - Related articles - All 16 versions
SA McKennon, RK Campbell - The Diabetes Educator, 2007 - tde.sagepub.com With the rising prevalence of diabetes, new therapies that provide glucose
control are needed. Although many medications are available, tight glucose
control is still a challenge. In this article, the physiology of glucose ... Cited by 5 - Related articles - BL Direct - All 2 versions
J Tibaldi - The American Journal of Medicine, 2008 - Elsevier Although insulin therapy for type 2 diabetes mellitus is perceived to be
challenging to initiate and intensify, it forms a vital part of treatment as the
disease progresses. This review discusses the challenges, real and ... Cited by 6 - Related articles - All 11 versions
AJ Garber - Diabetes, Obesity and Metabolism Supplement, 2002 - pt.wkhealth.com Abstract: Individuals with diabetes are at high risk of cardiovascular (CV)
disease, a risk that is significantly greater in the presence of traditional CV
risk factors (hyperlipidaemia, hypertension, prothrombotic state). Glucose ... Cited by 8 - Related articles - BL Direct - All 5 versions
[CITATION] Managing mental illness in patients with diabetes
